Movement Alert｜Bruker Rises 5.52% in Regular Trading, Multiple Investment Banks Raise Price Targets Boosting Market Confidence

Market Focus09-17

On September 17, Bruker rose 5.52% in regular trading, trading at $64.045/share, with turnover of $47.27 million.

On the news front, multiple major investment banks have significantly raised their price targets for Bruker. UBS adjusted its target from $45 to $65 on September 9 while maintaining a Neutral rating. Earlier, BofA Securities raised its target from $49 to $70. According to FactSet, the current analyst consensus rating is Overweight with a mean price target of $51.58 — a level the stock has now surpassed.

On the fundamentals side, Bruker reported Q2 adjusted earnings of $0.49 per diluted share, representing a 53% year-over-year increase from $0.32, significantly beating the analyst consensus estimate of $0.39. Revenue came in at $838.5 million, up from $797.4 million a year earlier. The company also recently announced strategic initiatives including a collaboration with Luvata on superconductors for fusion projects, a majority investment in Mimetas for disease biology research, and an expanded partnership with Atinary Technologies in AI-driven laboratory automation.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1123637375?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-17 23:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123637375","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Bruker Rises 5.52% in Regular Trading, Multiple Investment Banks Raise Price Targets Boosting Market Confidence","media":"Market Focus","content":"<p><p>On September 17, Bruker rose 5.52% in regular trading, trading at $64.045/share, with turnover of $47.27 million.</p><p>On the news front, multiple major investment banks have significantly raised their price targets for Bruker. UBS adjusted its target from $45 to $65 on September 9 while maintaining a Neutral rating. Earlier, BofA Securities raised its target from $49 to $70. According to FactSet, the current analyst consensus rating is Overweight with a mean price target of $51.58 — a level the stock has now surpassed.</p><p>On the fundamentals side, Bruker reported Q2 adjusted earnings of $0.49 per diluted share, representing a 53% year-over-year increase from $0.32, significantly beating the analyst consensus estimate of $0.39. Revenue came in at $838.5 million, up from $797.4 million a year earlier. The company also recently announced strategic initiatives including a collaboration with Luvata on superconductors for fusion projects, a majority investment in Mimetas for disease biology research, and an expanded partnership with Atinary Technologies in AI-driven laboratory automation.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Bruker Rises 5.52% in Regular Trading, Multiple Investment Banks Raise Price Targets Boosting Market Confidence</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Bruker Rises 5.52% in Regular Trading, Multiple Investment Banks Raise Price Targets Boosting Market Confidence\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-17 23:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 17, Bruker rose 5.52% in regular trading, trading at $64.045/share, with turnover of $47.27 million.</p><p>On the news front, multiple major investment banks have significantly raised their price targets for Bruker. UBS adjusted its target from $45 to $65 on September 9 while maintaining a Neutral rating. Earlier, BofA Securities raised its target from $49 to $70. According to FactSet, the current analyst consensus rating is Overweight with a mean price target of $51.58 — a level the stock has now surpassed.</p><p>On the fundamentals side, Bruker reported Q2 adjusted earnings of $0.49 per diluted share, representing a 53% year-over-year increase from $0.32, significantly beating the analyst consensus estimate of $0.39. Revenue came in at $838.5 million, up from $797.4 million a year earlier. The company also recently announced strategic initiatives including a collaboration with Luvata on superconductors for fusion projects, a majority investment in Mimetas for disease biology research, and an expanded partnership with Atinary Technologies in AI-driven laboratory automation.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BRKR","symbol_name":"布鲁克","start_time":0,"source_url":"","article_id":"1123637375","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123637375","pubTimestamp":1789659103,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 17, Bruker rose 5.52% in regular trading, trading at $64.045/share, with turnover of $47.27 million.On the news front, multiple major investment banks have significantly raised their...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BRKR":"布鲁克"},"translate_title":"走势警报|布鲁克常规交易上涨5.52%，多家投行上调目标价提振市场信心","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BRKR":1},"content_text":"On September 17, Bruker rose 5.52% in regular trading, trading at $64.045/share, with turnover of $47.27 million.On the news front, multiple major investment banks have significantly raised their price targets for Bruker. UBS adjusted its target from $45 to $65 on September 9 while maintaining a Neutral rating. Earlier, BofA Securities raised its target from $49 to $70. According to FactSet, the current analyst consensus rating is Overweight with a mean price target of $51.58 — a level the stock has now surpassed.On the fundamentals side, Bruker reported Q2 adjusted earnings of $0.49 per diluted share, representing a 53% year-over-year increase from $0.32, significantly beating the analyst consensus estimate of $0.39. Revenue came in at $838.5 million, up from $797.4 million a year earlier. The company also recently announced strategic initiatives including a collaboration with Luvata on superconductors for fusion projects, a majority investment in Mimetas for disease biology research, and an expanded partnership with Atinary Technologies in AI-driven laboratory automation.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1123637375","isCrawlerRequest":true}